Quantcast

Latest Interventional cardiology Stories

2014-02-04 16:28:02

FRAMINGHAM, Mass., Feb. 4, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the 2014 Leerink Global Healthcare Conference at 8:55 a.m. EST on Thursday, February 13, 2014. The conference is being held February 12-13 at the Waldorf Astoria in New York...

2014-01-31 12:25:45

PLEASANTON, Calif., Jan. 31, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Leerink Global Healthcare Conference on Wednesday, February 12. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company, beginning at 3:05 p.m., Eastern Standard Time (12:05 p.m., Pacific Standard...

2014-01-28 20:22:25

DUBLIN, Ireland, January 28, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/fvxjv3/cardiovascular) has announced the addition of a new report "Global Cardiovascular Drug Delivery Market" [http://www.researchandmarkets.com/research/fvxjv3/cardiovascular ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Drug delivery to the cardiovascular system is different from delivery to other systems because...

2014-01-27 16:23:02

Funding will support exploration of 'final frontier' in angioplasty KANSAS CITY, Mo., Jan. 27, 2014 /PRNewswire-USNewswire/ -- Saint Luke's Mid America Heart Institute has been awarded a $3.4 million, three-year grant from Boston Scientific to investigate and better define the success, safety, health benefits, and cost-effectiveness of novel methods to open challenging blocked coronary arteries previously thought untreatable through minimally invasive techniques. One in six...

2014-01-27 08:27:21

Latest Generation Device in Embolic Capture and Removal for Reducing Stroke during TAVR Procedures SANTA ROSA, Calif., Jan. 27, 2014 /PRNewswire/ -- Claret Medical, Inc., a developer of innovative solutions for cerebral protection during structural heart interventions, vascular interventions, and cardiac surgery procedures, announced that it has received CE Mark for the Sentinel(TM) Cerebral Protection System (CPS) for embolic protection during Transcatheter Aortic Valve Replacement...

2014-01-23 08:31:02

PLEASANTON, Calif., Jan. 23, 2014 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the fourth quarter of fiscal year 2013 on Tuesday, February 4. The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific...

2014-01-20 12:24:40

LONDON, Jan. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: MediPoint: Drug-Eluting Balloons - EU Analysis and Market Forecasts MediPoint: Drug-Eluting Balloons - EU Analysis and Market Forecasts Summary GlobalData has released its medical devices report, "MediPoint: Drug-Eluting Balloons - EU Analysis and Market Forecasts". The report provides in-depth insight into the use of DEB in the European Union (EU) for coronary and peripheral...

2014-01-20 08:22:43

SUNNYVALE, Calif., Jan. 20, 2014 /PRNewswire/ -- Cardiva Medical, Inc. announced today that Randy Hubbell has been appointed Chief Commercial Officer. He will be responsible for expanding commercialization efforts for Cardiva's portfolio of devices for femoral vascular closure including the VASCADE® Vascular Closure System and the Catalyst® closure wire. "Randy brings to Cardiva a unique blend of commercial expertise and strategic marketing that will prove invaluable to...

2014-01-16 20:22:09

FARMINGTON, Mich., Jan. 16, 2014 /PRNewswire/ -- /Continental Who's Who/ -- Dr. Mark Rasak, MD is recognized by Continental Who's Who as a Pinnacle Professional in the field of Medicine as a result of his role as CEO of Cardiovascular Clinical Associates. Dr. Rasak has over 15 years of experience and specializes in managing all major aspects of the business; overseeing the daily operations; interventional cardiology; complex coronary angioplasty; as well as primary coronary...

2014-01-14 16:26:14

Fourth Quarter 2013 Revenues Approximately $53 Million; up 62% from Q4 in 2012; 2013 Preliminary Revenues Approximately $208 Million; 87% increase from 2012 FRAMINGHAM, Mass., Jan. 14, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it expects revenues for the fourth quarter of 2013 will be...


Latest Interventional cardiology Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »
Word of the Day
toccata
  • In music, a work for a keyboard-instrument, like the pianoforte or organ, originally intended to utilize and display varieties of touch: but the term has been extended so as to include many irregular works, similar to the prelude, the fantasia, and the improvisation.
This word is Italian in origin, coming from the feminine past participle of 'toccare,' to touch.
Related